Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2024

May 13, 2024

SELL
$25.72 - $29.94 $218,620 - $254,490
-8,500 Reduced 1.57%
533,100 $14.5 Million
Q4 2023

Feb 14, 2024

BUY
$23.42 - $31.74 $224,832 - $304,704
9,600 Added 1.8%
541,600 $16.8 Million
Q3 2023

Nov 14, 2023

BUY
$19.86 - $26.93 $10.6 Million - $14.3 Million
532,000 New
532,000 $13.4 Million
Q2 2018

Aug 14, 2018

BUY
$20.0 - $29.72 $4.4 Million - $6.54 Million
220,000 New
220,000 $5.2 Million

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $10B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Balyasny Asset Management LLC Portfolio

Follow Balyasny Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.